Literature DB >> 15126328

MAT1-modulated cyclin-dependent kinase-activating kinase activity cross-regulates neuroblastoma cell G1 arrest and neurite outgrowth.

Shineng Zhang1, Qiaojun He, Hui Peng, Nicole Tedeschi-Blok, Timothy J Triche, Lingtao Wu.   

Abstract

Cyclin-dependent kinase-activating kinase (CAK) regulates cell cycle G1 exit, where cells commonly commit either to proliferate or to differentiate. CAK activity in G1 regulation is determined by its assembly factor and targeting subunit, ménage à trois 1 (MAT1). The precise mechanism of how proliferation/differentiation transition is induced from cancer cell G1 arrest remains unknown. We present evidence that in neuroblastoma CHP126 cells, CAK interacts with and phosphorylates retinoblastoma tumor suppressor protein (pRb) and retinoid X receptor alpha (RXRalpha). Retinoic acid (RA)-induced neuroblastoma cell proliferation/differentiation transition is associated with decreased CAK activity, as evidenced by a switch from CAK hyperphosphorylation of pRb and RXRalpha to hypophosphorylation of pRb and RXRalpha. Manipulation of MAT1 abundance shows that MAT1 reduction mimics RA-induced hypophosphorylation of pRb/RXRalpha, proliferation inhibition, and neurite outgrowth, whereas MAT1 overexpression resists these RA actions. Thus, these findings reveal an important mechanism by which MAT1-modulated CAK activity is crucial in the switch from proliferation to differentiation in neuroblastoma cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15126328     DOI: 10.1158/0008-5472.can-03-4018

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

Review 1.  Strategies to generate functionally normal neutrophils to reduce infection and infection-related mortality in cancer chemotherapy.

Authors:  Hisham Abdel-Azim; Weili Sun; Lingtao Wu
Journal:  Pharmacol Ther       Date:  2019-08-27       Impact factor: 12.310

2.  Novel susceptibility loci for second primary tumors/recurrence in head and neck cancer patients: large-scale evaluation of genetic variants.

Authors:  Xifeng Wu; Margaret R Spitz; J Jack Lee; Scott M Lippman; Yuanqing Ye; Hushan Yang; Fadlo R Khuri; Edward Kim; Jian Gu; Reuben Lotan; Waun K Hong
Journal:  Cancer Prev Res (Phila)       Date:  2009-07

3.  Loss of CAK phosphorylation of RAR{alpha} mediates transcriptional control of retinoid-induced cancer cell differentiation.

Authors:  Anxun Wang; Irina N Alimova; Peihua Luo; Ambrose Jong; Timothy J Triche; Lingtao Wu
Journal:  FASEB J       Date:  2009-11-16       Impact factor: 5.191

Review 4.  Role of cell cycle regulatory molecules in retinoic acid- and vitamin D3-induced differentiation of acute myeloid leukaemia cells.

Authors:  X T Hu; K S Zuckerman
Journal:  Cell Prolif       Date:  2014-03-19       Impact factor: 6.831

5.  MNAT1 is overexpressed in colorectal cancer and mediates p53 ubiquitin-degradation to promote colorectal cancer malignance.

Authors:  Shan Zhou; Jinping Lu; Yuejin Li; Chan Chen; Yongqiang Cai; Gongjun Tan; Zhengke Peng; Zhenlin Zhang; Zigang Dong; Tiebang Kang; Faqing Tang
Journal:  J Exp Clin Cancer Res       Date:  2018-11-26

6.  Inhibition of retinoic acid receptor α phosphorylation represses the progression of triple-negative breast cancer via transactivating miR-3074-5p to target DHRS3.

Authors:  Siyue Lou; Hang Gao; Huanwu Hong; Zhihui Zhu; Huajun Zhao
Journal:  J Exp Clin Cancer Res       Date:  2021-04-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.